Toyonaka, Japan

Fumio Itoh


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 59(Granted Patents)


Location History:

  • Toyonaka, JP (1995 - 2004)
  • Tsukuba, JP (2006 - 2009)
  • Osaka, JP (1998 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Fumio Itoh: Innovator in GSK-3β Inhibition and Receptor Agonists

Introduction

Fumio Itoh, located in Toyonaka, Japan, is a distinguished inventor known for his contributions to pharmaceutical innovations. With a remarkable portfolio of 10 patents, he has made significant strides in the fields of GSK-3β inhibition and receptor agonists.

Latest Patents

One of Itoh's latest patents focuses on GSK-3β inhibitors, providing an innovative approach for treating GSK-3β-related pathologies. The invention features an oxadiazole compound or its salts and prodrugs, aimed at delivering effective treatments. Another notable patent involves TGR5 receptor agonists comprising a fused ring compound. This invention is designed to facilitate the treatment of various diseases, employing a structure that enhances its efficacy.

Career Highlights

Fumio Itoh's career includes significant tenures at renowned organizations, including Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His work at these institutions has enabled him to push the boundaries of pharmaceutical research and development, contributing invaluable insights into drug mechanisms and therapeutic applications.

Collaborations

During his career, Itoh has collaborated with esteemed colleagues such as Hiroshi Banno and Tetsuya Aono. Together, they have worked on innovative projects that have expanded the understanding and capability of pharmaceutical treatments.

Conclusion

Fumio Itoh's dedication to innovation in pharmaceutical science has established him as a key figure in the development of important therapeutic agents. His patents not only reflect his expertise but also signify his commitment to improving health outcomes through advanced medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…